BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3938161)

  • 1. Philadelphia-chromosome-negative chronic myelogenous leukemia with incomplete trisomy 1q following chemotherapy for ovarian carcinoma.
    Haubenstock A; Zalusky R; Kim HJ; Kabakow B; Perle MA; Malamud SC; Vizel-Schwartz M
    Acta Haematol; 1985; 74(3):168-70. PubMed ID: 3938161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. t(1;2), inv(1) and trisomy 1q during the blastic phase of Philadelphia chromosome-positive chronic myeloid leukemia.
    Carbone P; Barbata G; Santoro A; Giglio MC; Mirto S; Granata G
    Acta Haematol; 1987; 77(4):198-202. PubMed ID: 3115029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Philadelphia chromosome-negative chronic myelogenous leukemia with trisomy D.
    Shashaty GG; Baumiller RC
    Arch Pathol Lab Med; 1980 Jul; 104(7):376-8. PubMed ID: 6930938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Philadelphia chromosome-negative chronic myelogenous leukemia with trisomy 13].
    Saigo K; Nakagawa T; Ryo R; Yamaguchi N
    Rinsho Ketsueki; 1995 Nov; 36(11):1295-9. PubMed ID: 8691571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial trisomy 1 due to 1/17 translocation in Ph'-positive chronic myelocytic leukemia.
    Pasquali F; Francesconi D; Casalone R; Ippoliti G
    Hum Genet; 1979 Jul; 49(3):277-282. PubMed ID: 289625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous regression of cytogenetic and haematologic anomalies in Ph1-positive chronic myelogenous leukaemia.
    Smadja N; Krulik M; Audebert AA; de Gramont A; Debray J
    Br J Haematol; 1986 Jun; 63(2):257-62. PubMed ID: 3459548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia.
    Wasilewska EM; Panasiuk B; Gniot M; Sawicka A; Kozłowska K; Lewandowski K; Kłoczko J; Midro AT
    Cancer Genet; 2017 Oct; 216-217():1-9. PubMed ID: 29025581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinoma terminating in acute nonlymphocytic leukemia following alkylating agent therapy.
    Kapadia SB; Krause JR
    Cancer; 1978 May; 41(5):1676-9. PubMed ID: 417794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytogenetic findings in chronic myelogenous leukemia].
    Prösch U; Stobbe H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):495-514. PubMed ID: 2414179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy 11 in a patient with Ph-negative chronic myelogenous leukemia.
    Yamada T; Sasaki M; Kawamura T
    Cancer Genet Cytogenet; 1986 Apr; 21(4):343-5. PubMed ID: 3456825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-triploid Ph-positive leukemia.
    Ohtaki K; Abe R; Tebbi CK; de los Santos R; Han T; Sandberg AA
    Cancer Genet Cytogenet; 1985 Oct; 18(2):113-21. PubMed ID: 3863695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Philadelphia chromosome positive acute lymphoblastic leukemia with partial trisomy of chromosome 1q involving chromosome 13 as the acceptor-A novel cytogenetic finding.
    Bharadwaj M; Sharma A; Katara R; Pradhan D; Arora R; Mittal R; Mohanty SK
    Pathol Res Pract; 2017 Jan; 213(1):72-74. PubMed ID: 27894622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome changes in a patient achieving complete remission in the acute phase of chronic myelogenous leukemia.
    Stern R; Sorenson J; Wurster-Hill DH; Cornwell GG; McIntyre OR
    Am J Hematol; 1979; 6(2):155-61. PubMed ID: 289290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete or partial trisomy for the long arm of chromosome 1 in patients with various hematologic malignancies.
    Mamaeva SE; Mamaev NN; Jartseva NM; Belyaeva LV; Scherbakova EG
    Hum Genet; 1983; 63(2):107-12. PubMed ID: 6573295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.
    Kim M; Lee S; Jung CK; Lim J; Cho SG; Kim DW; Kim Y; Han K; Min WS; Kim CC
    Int J Lab Hematol; 2008 Dec; 30(6):508-12. PubMed ID: 18983302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inversion of chromosome 3 in a case of chronic myelogenous leukemia with abnormal thrombopoiesis.
    Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H; Nishida K; Misawa S
    Cancer Genet Cytogenet; 1986 Feb; 20(1-2):121-7. PubMed ID: 3455854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
    O'Dwyer ME; Gatter KM; Loriaux M; Druker BJ; Olson SB; Magenis RE; Lawce H; Mauro MJ; Maziarz RT; Braziel RM
    Leukemia; 2003 Mar; 17(3):481-7. PubMed ID: 12646934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetics of chronic myelogenous leukemia.
    Bernstein R
    Semin Hematol; 1988 Jan; 25(1):20-34. PubMed ID: 3279513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Historical communication: Philadelphia-positive chronic myelogenous leukemia followed for 27 years.
    Nowell PC; Jackson L; Weiss A; Kurzrock R
    Cancer Genet Cytogenet; 1988 Aug; 34(1):57-61. PubMed ID: 3165050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual case of Philadelphia chromosome-positive chronic myelogenous leukemia with trisomy 19 presenting with megakaryoblastosis and myelofibrosis.
    Aljinovic N; Bogusz AM; Kantarci S; Buck TP; Dewar R
    Arch Pathol Lab Med; 2013 Aug; 137(8):1147-51. PubMed ID: 23899072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.